ArticleFrontiers in public health2026
Cancer center leadership during large-scale crises: a practical evidence-informed framework with perspectives from the Gulf Cooperation Council.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer centers are disproportionately vulnerable to large-scale crises-including pandemics, armed conflicts, cyberattacks, and supply chain failures-and while COVID-19 generated valuable crisis guidance for oncology, frameworks tailored to the specific structural vulnerabilities of GCC cancer systems have been limited. The Gulf Cooperation Council region illustrates this gap with immediate, real-time urgency. The ongoing 2026 regional military escalation has reportedly disrupted Strait of Hormuz shipping and Gulf air cargo routes-critical corridors for pharmaceutical cold-chain logistics across all six GCC states-posing risks to essential oncology pharmaceuticals, radioisotopes used in nuclear medicine, and CAR-T manufacturing supply chains. Cancer incidence across the GCC is projected to increase by 60% by 2040, and cancer care remains under-integrated into emergency preparedness frameworks globally. This Perspective proposes a six-pillar crisis leadership framework for cancer center directors and oncology leaders, organized across a four-phase crisis lifecycle (Prepare, Respond, Adapt, Recover), drawing on pandemic-era oncology evidence, international oncology society guidelines, and contextual analysis of the 2026 GCC crisis. The six pillars address the full operational spectrum of cancer center crisis management, from triage and pharmaceutical resilience to workforce wellbeing, digital health, and cross-border coordination. Three specific policy recommendations for GCC health systems are proposed: a formal GCC Oncology Crisis Network with a Regional Real-Time Pharmaceutical Dashboard and distributed reserve framework spanning UAE, Saudi Arabia, and Oman; domestic manufacturing investment for oncology essentials; and a GCC oncology resilience research agenda.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.